- Home
- Publications
- Publication Search
- Publication Details
Title
Macrophages as tools and targets in cancer therapy
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-17
DOI
10.1038/s41573-022-00520-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial
- (2022) Georg Martin Haag et al. EUROPEAN JOURNAL OF CANCER
- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
- (2021) Jiali Yu et al. NATURE MEDICINE
- Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
- (2021) David A. Braun et al. CANCER CELL
- A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
- (2021) Sijin Cheng et al. CELL
- Therapeutic Manipulation of Tumor-associated Macrophages: Facts and Hopes from a Clinical and Translational Perspective
- (2021) Paola Allavena et al. CLINICAL CANCER RESEARCH
- Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion
- (2021) Isak W. Tengesdal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
- (2021) Alba Rodriguez-Garcia et al. Nature Communications
- Seeing the forest for the trees—single-cell atlases link CD8+ T cells and macrophages to disease progression and treatment response in kidney cancer
- (2021) Mei Yee Koh et al. CANCER CELL
- Interleukin-1 in tumor progression, therapy, and prevention
- (2021) Cecilia Garlanda et al. CANCER CELL
- Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
- (2021) Chirag Krishna et al. CANCER CELL
- Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis
- (2021) Sabina Kaczanowska et al. CELL
- Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
- (2021) Ester Gangoso et al. CELL
- Redefining macrophage and neutrophil biology in the metastatic cascade
- (2021) Esra Güç et al. IMMUNITY
- LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy
- (2021) Naveen Sharma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization
- (2021) Ana Rita Pombo Antunes et al. NATURE NEUROSCIENCE
- Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them
- (2021) Shan-Shan Zou et al. PHARMACOLOGICAL RESEARCH
- PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response
- (2021) Jie Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer
- (2021) Owen Heath et al. Cancer Immunology Research
- Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy
- (2021) Stephen L. Shiao et al. CANCER CELL
- Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
- (2021) Andrew Chow et al. CANCER CELL
- Activating a collaborative innate-adaptive immune response to control metastasis
- (2021) Lijuan Sun et al. CANCER CELL
- Spatially organized multicellular immune hubs in human colorectal cancer
- (2021) Karin Pelka et al. CELL
- Systemic blockade of Clever-1 elicits lymphocyte activation alongside checkpoint molecule downregulation in patients with solid tumors: Results from a phase I/II clinical trial
- (2021) Reetta Virtakoivu et al. CLINICAL CANCER RESEARCH
- A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
- (2021) Gulam A. Manji et al. CLINICAL CANCER RESEARCH
- Preliminary results from a phase 1/2 study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors.
- (2021) Manish Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I-IIa study of genetically modified Tie-2 expressing monocytes in patients with glioblastoma multiforme (TEM-GBM Study).
- (2021) Gaetano Finocchiaro et al. JOURNAL OF CLINICAL ONCOLOGY
- Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells
- (2021) María Casanova-Acebes et al. NATURE
- Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity
- (2021) Itziar Ibarlucea-Benitez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
- (2021) Rosalynd Upton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan deposition
- (2021) Stefan Bissinger et al. Science Translational Medicine
- Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models
- (2021) Amaia Martinez-Usatorre et al. Science Translational Medicine
- Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy
- (2021) Victoria S. Pelly et al. Cancer Discovery
- Overcoming PD-1 Blockade Resistance With CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients With Metastatic Melanoma
- (2021) Antoni Ribas et al. Cancer Discovery
- Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade
- (2021) Marie V. Daugan et al. Cancer Immunology Research
- Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
- (2021) Clément Anfray et al. Journal for ImmunoTherapy of Cancer
- Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification
- (2021) Andrew M. Leader et al. CANCER CELL
- The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
- (2021) Hongzhong Li et al. CANCER CELL
- Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
- (2021) Khiem C. Lam et al. CELL
- Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
- (2021) Srivatsan Raghavan et al. CELL
- Discovering dominant tumor immune archetypes in a pan-cancer census
- (2021) Alexis J. Combes et al. CELL
- Targeting Fc Receptor-Mediated Effects and the “Don't Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer
- (2021) Lei Tian et al. CLINICAL CANCER RESEARCH
- First-in-Class Anti-immunoglobulin–like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors
- (2021) Lillian L. Siu et al. CLINICAL CANCER RESEARCH
- B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity
- (2021) Baihao Zhang et al. NATURE
- Targeting TREM2 on tumor-associated macrophages enhances immunotherapy
- (2021) Mikhail Binnewies et al. Cell Reports
- Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic Cells
- (2021) Christina Pfirschke et al. Cancer Immunology Research
- Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
- (2021) Christopher Sloas et al. Frontiers in Immunology
- The depths of PD-1 function within the tumor microenvironment beyond CD8+ T cells
- (2021) Stephanie Laba et al. SEMINARS IN CANCER BIOLOGY
- Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer
- (2020) Anders Etzerodt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Biology and therapeutic targeting of tumour‐associated macrophages
- (2020) Tim Beltraminelli et al. JOURNAL OF PATHOLOGY
- Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses
- (2020) Jesse M. Jaynes et al. Science Translational Medicine
- Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
- (2020) Laura Strauss et al. Science Immunology
- Macrophage targeting in cancer
- (2020) Martha Lopez‐Yrigoyen et al. Annals of the New York Academy of Sciences
- Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC
- (2020) Chiara Porta et al. CANCER RESEARCH
- Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression
- (2020) Samir Devalaraja et al. CELL
- Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
- (2020) Lei Zhang et al. CELL
- Toll-like Receptors and the Control of Immunity
- (2020) Katherine A. Fitzgerald et al. CELL
- Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
- (2020) Ekaterina Friebel et al. CELL
- Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
- (2020) Florian Klemm et al. CELL
- PLGA Based Nanoparticles for the Monocyte-Mediated Anti-Tumor Drug Delivery System
- (2020) Paola Allavena et al. Journal of Biomedical Nanotechnology
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- Divergent Roles for Macrophage C-type Lectin Receptors, Dectin-1 and Mannose Receptors, in the Intestinal Inflammatory Response
- (2020) Mouna Rahabi et al. Cell Reports
- Cellular backpacks for macrophage immunotherapy
- (2020) C. Wyatt Shields et al. Science Advances
- IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis
- (2020) Rasmus Siersbæk et al. CANCER CELL
- Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity
- (2020) Yan Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer
- (2020) Yonatan Katzenelenbogen et al. CELL
- TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy
- (2020) Martina Molgora et al. CELL
- Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial
- (2020) Shuhong Wang et al. CLINICAL CANCER RESEARCH
- Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
- (2020) Anaelle A Dumas et al. EMBO JOURNAL
- Determinants of Resident Tissue Macrophage Identity and Function
- (2020) Camille Blériot et al. IMMUNITY
- Nucleic Acid Sensors as Therapeutic Targets for Human Disease
- (2020) Sarah M. McWhirter et al. IMMUNITY
- Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
- (2020) Min-Hee Oh et al. JOURNAL OF CLINICAL INVESTIGATION
- Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth
- (2020) Ruo-Yu Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity
- (2020) Austin P. Huffman et al. JCI Insight
- Inhibition of IL-1β by canakinumab may be effective against diverse molecular subtypes of lung cancer: an exploratory analysis of the CANTOS trial
- (2020) Connie C Wong et al. CANCER RESEARCH
- Glufosinate constrains synchronous and metachronous metastasis by promoting anti‐tumor macrophages
- (2020) Alessio Menga et al. EMBO Molecular Medicine
- Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors
- (2020) Iván Márquez-Rodas et al. Science Translational Medicine
- Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma
- (2020) Anusha Kalbasi et al. Science Translational Medicine
- Prognostic significance of tumor-associated macrophages: past, present and future
- (2020) Nina Cortese et al. SEMINARS IN IMMUNOLOGY
- Toll-Like Receptor 9 Agonists in Cancer
- (2020) Lilit Karapetyan et al. OncoTargets and Therapy
- Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion
- (2020) Bianca Cioni et al. Nature Communications
- Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
- (2020) Albiruni RA Razak et al. Journal for ImmunoTherapy of Cancer
- Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
- (2020) Leila Motedayen Aval et al. Journal of Clinical Medicine
- Targeting MARCO and IL-37R on immunosuppressive macrophages in lung cancer blocks regulatory T cells and supports cytotoxic lymphocyte function
- (2020) Linnéa La Fleur et al. CANCER RESEARCH
- FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
- (2020) Sonia Singh et al. CLINICAL CANCER RESEARCH
- Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour
- (2020) Philippe A. Cassier et al. EUROPEAN JOURNAL OF CANCER
- Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
- (2020) Eduardo Bonavita et al. IMMUNITY
- CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
- (2020) Mark H O'Hara et al. LANCET ONCOLOGY
- Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells
- (2020) Silke Eisinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gut microbiome directs hepatocytes to recruit MDSC and promote cholangiocarcinoma
- (2020) Qianfei Zhang et al. Cancer Discovery
- Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
- (2019) Karim Vermaelen Frontiers in Immunology
- Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer
- (2019) Sunil Singhal et al. Science Translational Medicine
- Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
- (2019) Camilla Salvagno et al. NATURE CELL BIOLOGY
- Targeted Delivery of miRNA 155 to Tumor Associated Macrophages for Tumor Immunotherapy
- (2019) Xinlong Zang et al. MOLECULAR PHARMACEUTICS
- Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T Cell Response Against Immunosuppressive Tumors
- (2019) Miro K Viitala et al. CLINICAL CANCER RESEARCH
- Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
- (2019) Luca Cassetta et al. CANCER CELL
- Phase I Study of Emactuzumab Single Agent or in Combination with Paclitaxel in Patients with Advanced/Metastatic Solid Tumors Reveals Depletion of Immunosuppressive M2-like Macrophages
- (2019) C A Gomez-Roca et al. ANNALS OF ONCOLOGY
- Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
- (2019) Alberto Mantovani et al. IMMUNITY
- Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
- (2019) Rapolas Zilionis et al. IMMUNITY
- Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial
- (2019) Niannian Ji et al. OncoImmunology
- Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator
- (2019) Ruolin Lu et al. JOURNAL OF CONTROLLED RELEASE
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- Tumor cells hijack macrophage-produced complement C1q to promote tumor growth
- (2019) Lubka T. Roumenina et al. Cancer Immunology Research
- Complementing the Cancer-Immunity Cycle
- (2019) Ruben Pio et al. Frontiers in Immunology
- Tuning the Tumor Myeloid Microenvironment to Fight Cancer
- (2019) Nadine S. Jahchan et al. Frontiers in Immunology
- MicroRNAs as Molecular Switches in Macrophage Activation
- (2019) Graziella Curtale et al. Frontiers in Immunology
- Diversity, Mechanisms, and Significance of Macrophage Plasticity
- (2019) Massimo Locati et al. Annual Review of Pathology-Mechanisms of Disease
- Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
- (2019) Wenlong Zhang et al. BRITISH JOURNAL OF CANCER
- Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer
- (2019) Paweł Bieniasz-Krzywiec et al. Cell Metabolism
- Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression
- (2019) Anders Etzerodt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms
- (2019) Ik Sun Kim et al. NATURE CELL BIOLOGY
- Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
- (2019) Claire Vanpouille-Box et al. NATURE REVIEWS DRUG DISCOVERY
- VISTA is an acidic pH-selective ligand for PSGL-1
- (2019) Robert J. Johnston et al. NATURE
- Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology
- (2019) David H. Gutmann et al. NEURON
- Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
- (2019) F. Zhang et al. Nature Communications
- Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages
- (2019) Weiqiang Jing et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis
- (2019) Rohit Singh et al. eLife
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- Therapeutic Immune Modulation Against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
- (2018) Chrisann Kyi et al. CLINICAL CANCER RESEARCH
- PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
- (2018) Haidong Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
- (2018) Sabine Hoves et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phenotype molding of stromal cells in the lung tumor microenvironment
- (2018) Diether Lambrechts et al. NATURE MEDICINE
- Mechanisms of BCG immunotherapy and its outlook for bladder cancer
- (2018) Caroline Pettenati et al. Nature Reviews Urology
- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T cell–induced CSF1 promotes melanoma resistance to PD1 blockade
- (2018) Natalie J. Neubert et al. Science Translational Medicine
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
- (2018) Smruti Pushalkar et al. Cancer Discovery
- Chimeric antigen receptors that trigger phagocytosis
- (2018) Meghan A Morrissey et al. eLife
- Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck
- (2018) Robert L. Ferris et al. JAMA Oncology
- IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
- (2018) Arianna Calcinotto et al. NATURE
- In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
- (2018) Matthew J. Frank et al. Cancer Discovery
- Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy
- (2018) Terry R. Medler et al. CANCER CELL
- Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis
- (2018) Brian W. Labadie et al. CLINICAL CANCER RESEARCH
- Developmental and Functional Heterogeneity of Monocytes
- (2018) Martin Guilliams et al. IMMUNITY
- Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity
- (2018) Hui-Ming Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- The obese adipose tissue microenvironment in cancer development and progression
- (2018) Daniela F. Quail et al. Nature Reviews Endocrinology
- Macrophage Checkpoint Blockade in Cancer — Back to the Future
- (2018) Alberto Mantovani et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
- (2018) Irena Kaplanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors
- (2018) David Argyle et al. Frontiers in Immunology
- Trial Watch: Toll-like receptor agonists in cancer immunotherapy
- (2018) Melody Smith et al. OncoImmunology
- Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression
- (2017) Yu Zhu et al. IMMUNITY
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells
- (2017) Joshua D. Stender et al. MOLECULAR CELL
- IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity
- (2017) Martina Molgora et al. NATURE
- Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
- (2017) Jennifer L. Guerriero et al. NATURE
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
- (2017) Nan Guo Ring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
- (2017) Sharareh Gholamin et al. Science Translational Medicine
- A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis
- (2017) Daniel Ajona et al. Cancer Discovery
- 2-Deoxy-d-Glucose Treatment Decreases Anti-inflammatory M2 Macrophage Polarization in Mice with Tumor and Allergic Airway Inflammation
- (2017) Qingjie Zhao et al. Frontiers in Immunology
- Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer
- (2017) Alberto Malesci et al. OncoImmunology
- Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer
- (2017) Marcello Rubino et al. OncoImmunology
- CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab
- (2017) Peter E. van Bommel et al. OncoImmunology
- Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
- (2016) Federico Pietrocola et al. CANCER CELL
- Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity
- (2016) Stefano Di Biase et al. CANCER CELL
- Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN
- (2016) Laura Q.M. Chow et al. CLINICAL CANCER RESEARCH
- Tissue-Resident Macrophage Ontogeny and Homeostasis
- (2016) Florent Ginhoux et al. IMMUNITY
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
- (2016) Timothy M Nywening et al. LANCET ONCOLOGY
- Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
- (2016) Caroline Baer et al. NATURE CELL BIOLOGY
- The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis
- (2016) Ido Amit et al. NATURE IMMUNOLOGY
- Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
- (2016) Teresa E. Peterson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
- (2016) Jonas Kloepper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Long-lived self-renewing bone marrow-derived macrophages displace embryo-derived cells to inhabit adult serous cavities
- (2016) Calum C. Bain et al. Nature Communications
- Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
- (2016) Anna-Maria Georgoudaki et al. Cell Reports
- Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
- (2016) Michael Zhang et al. PLoS One
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer
- (2015) N. Gul et al. CANCER RESEARCH
- PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
- (2015) Eduardo Bonavita et al. CELL
- Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy
- (2015) Giuseppe Di Caro et al. GUT
- Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization
- (2015) Abhishek K. Jha et al. IMMUNITY
- Metabolic Reprogramming of Immune Cells in Cancer Progression
- (2015) Subhra K. Biswas IMMUNITY
- CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
- (2015) Takanori Kitamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation
- (2015) S E M Heinsbroek et al. Mucosal Immunology
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions
- (2015) D. J. DiLillo et al. Cancer Immunology Research
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
- (2014) S. K. Vadrevu et al. CANCER RESEARCH
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
- (2014) Y. Zhu et al. CANCER RESEARCH
- Tissue-Specific Signals Control Reversible Program of Localization and Functional Polarization of Macrophages
- (2014) Yasutaka Okabe et al. CELL
- Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
- (2014) Yonit Lavin et al. CELL
- Environment Drives Selection and Function of Enhancers Controlling Tissue-Specific Macrophage Identities
- (2014) David Gosselin et al. CELL
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Resident microglia, and not peripheral macrophages, are the main source of brain tumor mononuclear cells
- (2014) Annett Müller et al. INTERNATIONAL JOURNAL OF CANCER
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Liver X receptors in lipid metabolism: opportunities for drug discovery
- (2014) Cynthia Hong et al. NATURE REVIEWS DRUG DISCOVERY
- Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences
- (2013) F. O. Martinez et al. BLOOD
- A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies
- (2013) Gert J. Ossenkoppele et al. BRITISH JOURNAL OF HAEMATOLOGY
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
- (2013) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
- (2013) O. Bloch et al. CLINICAL CANCER RESEARCH
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
- (2013) D. Tseng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
- (2012) J. B. Mitchem et al. CANCER RESEARCH
- Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein
- (2012) S Bobadilla et al. GENE THERAPY
- Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
- (2012) Kenneth J. Pienta et al. INVESTIGATIONAL NEW DRUGS
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- Engagement of the Mannose Receptor by Tumoral Mucins Activates an Immune Suppressive Phenotype in Human Tumor-Associated Macrophages
- (2011) P. Allavena et al. Clinical & Developmental Immunology
- Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages
- (2011) Senthil Palani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
- (2011) Li Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human Immunodeficiency Virus Type 1 Modified To Package Simian Immunodeficiency Virus Vpx Efficiently Infects Macrophages and Dendritic Cells
- (2011) N. Sunseri et al. JOURNAL OF VIROLOGY
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
- (2010) K. Movahedi et al. CANCER RESEARCH
- Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
- (2010) Federica Marchesi et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- CCL2 Blockade Augments Cancer Immunotherapy
- (2009) Z. G. Fridlender et al. CANCER RESEARCH
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- Macrophage Markers in Serum and Tumor Have Prognostic Impact in American Joint Committee on Cancer Stage I/II Melanoma
- (2009) Trine O. Jensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
- (2009) Dong-Ming Kuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Systemic effects of local radiotherapy
- (2009) Silvia C Formenti et al. LANCET ONCOLOGY
- Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis
- (2008) Michele De Palma et al. CANCER CELL
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- A role for VEGF as a negative regulator of pericyte function and vessel maturation
- (2008) Joshua I. Greenberg et al. NATURE
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started